90-day Pod-type Etonogestrel/Ethinyl Estradiol/QGriffithsin (QGRFT) Intravaginal Ring [EEQ IVR]
Status:Ongoing
Phase:Pre-clinical
Principal Investigator(s):TELESHOVA, NATALIA
Objective:A 90-day pod-type MPT IVR for pregnancy and HIV prevention that could reduce both the emergence of ARV-resistant HIV and the concern of potential increased risk of HIV transmission associated with use of progestin-only products.
Prevention Option(s):Microbicides
Study Design:
Arms and Assigned Interventions
Description
Mode of DeliveryRing
ARMs
Trial Sponsors:
NIAID
Start Date
End Date
April 7, 2020
March 31, 2025
Enrollment:0
Age range:
↔
any
Population: